SCL · Stepan Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $604.51M | - | $590.28M | $594.69M | $593.25M | - | $546.84M | $556.40M | $551.42M | - |
| Cost of Revenue | $539.66M | - | $519.26M | $522.80M | $517.79M | - | $471.16M | $486.85M | $481.14M | - |
| Gross Profit | $64.85M | - | $71.02M | $71.89M | $75.46M | - | $75.69M | $69.55M | $70.28M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $21.31M | - | $22.86M | $22.80M | $21.41M | - | $26.25M | $24.57M | $22.69M | - |
| Total Operating Expenses | $49.03M | - | $49.23M | $53.92M | $47.17M | - | $51.74M | $50.88M | $50.11M | - |
| D&A | $32.95M | - | $28.06M | $28.01M | $29.27M | - | - | - | $27.60M | - |
| Operating Income | ($49.62M) | - | $21.79M | $17.96M | $28.29M | - | $23.95M | $18.67M | $20.17M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | ($13.08M) | - | $5.68M | $2.44M | $4.95M | - | ($2.29M) | $7.68M | $5.57M | - |
| Net Income | ($41.41M) | - | $10.84M | $11.34M | $19.71M | - | $23.61M | $9.52M | $13.89M | - |
| EPS - Basic | ($1.81) | - | $0.47 | $0.50 | $0.86 | - | $1.03 | $0.42 | $0.61 | - |
| EPS - Diluted | ($1.81) | - | $0.47 | $0.50 | $0.86 | - | $1.03 | $0.42 | $0.61 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140.78M | $132.69M | $118.54M | $88.90M | $107.49M | $99.67M | $147.28M | $124.71M | $125.78M | $129.82M |
| Accounts Receivable | $433.69M | $387.96M | $436.14M | $442.15M | $436.49M | $388.03M | $434.15M | $437.35M | $446.57M | $422.05M |
| Inventory | $289.02M | $298.83M | $324.27M | $329.48M | $309.33M | $288.72M | $296.70M | $266.01M | $257.12M | $265.56M |
| Accounts Payable | $285.70M | $261.72M | $289.38M | $281.75M | $298.13M | $258.79M | $257.07M | $251.19M | $256.88M | $233.03M |
| Current Assets | $906.24M | $858.96M | $920.60M | $906.11M | $897.16M | $810.43M | $918.16M | $867.14M | $869.81M | $851.88M |
| Total Assets | $2.33B | $2.36B | $2.43B | $2.42B | $2.39B | $2.30B | $2.41B | $2.35B | $2.37B | $2.36B |
| Current Liabilities | $720.45M | $666.49M | $709.35M | $673.02M | $739.48M | $669.03M | $721.29M | $655.20M | $628.85M | $607.87M |
| Long-term Debt | $328.42M | $340.98M | $357.11M | $383.24M | $330.80M | $332.63M | $348.67M | $374.71M | $400.12M | $401.25M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $1.19B | $1.24B | $1.25B | $1.24B | $1.20B | $1.17B | $1.22B | $1.19B | $1.21B | $1.22B |
| Retained Earnings | $1.24B | $1.29B | $1.29B | $1.29B | $1.28B | $1.27B | $1.28B | $1.26B | $1.26B | $1.26B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $16.93M | - | - | - | $6.94M | - | - | - | $41.55M | - |
| Investing Cash Flow | ($22.91M) | - | - | - | ($26.41M) | - | - | - | ($24.41M) | - |
| Financing Cash Flow | $13.60M | - | - | - | $22.76M | - | - | - | ($19.98M) | - |
| CapEx | $30.89M | - | - | - | $32.75M | - | - | - | $30.16M | - |
| Free Cash Flow | ($13.95M) | - | - | - | ($25.81M) | - | - | - | $11.40M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 10.7% | - | 12.0% | 12.1% | 12.7% | - | 13.8% | 12.5% | 12.7% | - |
| Operating margin | -8.2% | - | 3.7% | 3.0% | 4.8% | - | 4.4% | 3.4% | 3.7% | - |
| EBITDA margin | -2.8% | - | 8.4% | 7.7% | 9.7% | - | - | - | 8.7% | - |
| Net margin | -6.8% | - | 1.8% | 1.9% | 3.3% | - | 4.3% | 1.7% | 2.5% | - |
| Free cash flow margin | -2.3% | - | - | - | -4.3% | - | - | - | 2.1% | - |
| FCF / Net income | 0.34 | - | - | - | -1.31 | - | - | - | 0.82 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 3.5% | - | 3.9% | 3.8% | 3.6% | - | 4.8% | 4.4% | 4.1% | - |
| Effective tax rate | - | - | 34.4% | 17.7% | 20.1% | - | -10.7% | 44.7% | 28.6% | - |
| Return on assets | -1.8% | - | 0.4% | 0.5% | 0.8% | - | 1.0% | 0.4% | 0.6% | - |
| Return on equity | -3.5% | - | 0.9% | 0.9% | 1.6% | - | 1.9% | 0.8% | 1.1% | - |
| Return on invested capital | -2.6% | - | 0.9% | 0.9% | 1.5% | - | 1.5% | 0.7% | 0.9% | - |
| Liquidity | ||||||||||
| Current ratio | 1.26 | 1.29 | 1.30 | 1.35 | 1.21 | 1.21 | 1.27 | 1.32 | 1.38 | 1.40 |
| Quick ratio | 0.86 | 0.84 | 0.84 | 0.86 | 0.79 | 0.78 | 0.86 | 0.92 | 0.97 | 0.96 |
| Cash ratio | 0.20 | 0.20 | 0.17 | 0.13 | 0.15 | 0.15 | 0.20 | 0.19 | 0.20 | 0.21 |
| Leverage | ||||||||||
| Debt / Equity | 0.28 | 0.27 | 0.29 | 0.31 | 0.28 | 0.28 | 0.29 | 0.31 | 0.33 | 0.33 |
| Debt / Assets | 0.14 | 0.14 | 0.15 | 0.16 | 0.14 | 0.14 | 0.14 | 0.16 | 0.17 | 0.17 |
| Debt / EBITDA | - | - | 7.16 | 8.34 | 5.75 | - | - | - | 8.38 | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.96 | 1.90 | 1.95 | 1.95 | 1.99 | 1.97 | 1.98 | 1.97 | 1.95 | 1.94 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.26 | - | 0.24 | 0.25 | 0.25 | - | 0.23 | 0.24 | 0.23 | - |
| Inventory turnover | 1.87 | - | 1.60 | 1.59 | 1.67 | - | 1.59 | 1.83 | 1.87 | - |
| Days sales outstanding | 262d | - | 270d | 271d | 269d | - | 290d | 287d | 296d | - |
| Days inventory outstanding | 195d | - | 228d | 230d | 218d | - | 230d | 199d | 195d | - |
| Days payable outstanding | 193d | - | 203d | 197d | 210d | - | 199d | 188d | 195d | - |
| Cash conversion cycle | 264d | - | 294d | 305d | 276d | - | 320d | 298d | 296d | - |
| Valuation | ||||||||||
| P / E | - | - | 101.5x | 109.2x | 64.0x | - | 75.0x | 199.9x | 147.6x | - |
| P / B | 1.0x | - | 0.9x | 1.0x | 1.0x | - | 1.5x | 1.6x | 1.7x | - |
| P / S | 1.9x | - | 1.8x | 2.1x | 2.1x | - | 3.2x | 3.5x | 3.7x | - |
| EV / EBITDA | - | - | 26.7x | 33.6x | 25.8x | - | - | - | 49.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 1.9% | - | 7.9% | 6.9% | 7.6% | - | -2.7% | -4.1% | -15.4% | - |
| Revenue CAGR (3y) | -2.5% | - | -6.4% | -7.5% | -4.2% | - | -3.2% | -2.2% | 0.8% | - |
| Revenue CAGR (5y) | 2.4% | - | 4.9% | 5.2% | 5.7% | - | 3.9% | 3.3% | 2.4% | - |
| Gross profit growth (YoY) | -14.1% | - | -6.2% | 3.4% | 7.4% | - | 6.2% | 4.8% | -4.5% | - |
| Operating income growth (YoY) | - | - | -9.0% | -3.8% | 40.3% | - | 22.7% | 4.8% | -4.2% | - |
| Net income growth (YoY) | - | - | -54.1% | 19.1% | 41.9% | - | 87.8% | -24.9% | -13.9% | - |
| EPS growth (YoY) | - | - | -54.4% | 19.0% | 41.0% | - | 87.3% | -23.6% | -12.9% | - |
| EPS CAGR (3y) | - | - | -35.0% | -39.5% | -23.6% | - | -13.5% | -39.0% | -29.5% | - |
| EPS CAGR (5y) | - | - | -20.0% | -20.1% | -6.1% | - | -1.5% | -20.2% | -10.6% | - |
| FCF growth (YoY) | 45.9% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -0.6% | 6.3% | 2.2% | 4.1% | -1.2% | -3.8% | 1.4% | -1.9% | 2.1% | 4.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$2.33B totalSurfactants$1.67B · 71.4%
Polymers$584.48M · 25.1%
Specialty Products$81.65M · 3.5%
Geographic
$4.00B totalUS$1.30B · 32.5%
North America$954.05M · 23.9%
Latin America$357.05M · 8.9%
Europe$306.99M · 7.7%
FR$211.45M · 5.3%
All Other Countries$181.57M · 4.5%
GB$169.91M · 4.2%
MX$164.01M · 4.1%
BR$156.24M · 3.9%
PL$148.94M · 3.7%
Asia$47.88M · 1.2%
Peer comparison
Same SIC group: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Comparing STEPAN CO against the 5 most active filers in the same SIC group.
Dividends
$1.57/share trailing 12 months · +2.6% YoY
| Ex-date | Per share |
|---|---|
| Jun 1, 2026 | $0.3950 |
| Mar 2, 2026 | $0.3950 |
| Nov 28, 2025 | $0.3950 |
| Aug 29, 2025 | $0.3850 |
| May 30, 2025 | $0.3850 |
| Mar 3, 2025 | $0.3850 |
| Nov 29, 2024 | $0.3850 |
| Aug 30, 2024 | $0.3750 |
| May 31, 2024 | $0.3750 |
| Feb 29, 2024 | $0.3750 |
| Nov 29, 2023 | $0.3750 |
| Aug 30, 2023 | $0.3650 |
| May 30, 2023 | $0.3650 |
| Mar 2, 2023 | $0.3650 |
| Nov 29, 2022 | $0.3650 |
| Aug 30, 2022 | $0.3350 |
| May 27, 2022 | $0.3350 |
| Mar 3, 2022 | $0.3350 |
| Nov 29, 2021 | $0.3350 |
| Aug 30, 2021 | $0.3050 |
| May 27, 2021 | $0.3050 |
| Mar 4, 2021 | $0.3050 |
| Nov 27, 2020 | $0.3050 |
| Aug 28, 2020 | $0.2750 |